GLEM LIN MXR 10/5/1000MG TAB

GLEM LIN MXR is a triple-action combination tablet designed for comprehensive diabetes management. Each tablet contains Empagliflozin 10mg, Linagliptin 5mg, and Metformin 1000mg—three proven antidiabetic agents working synergistically to improve glycemic control. Empagliflozin helps reduce blood glucose by promoting urinary glucose excretion, while Linagliptin enhances insulin secretion by inhibiting DPP-4 enzymes. Metformin improves insulin sensitivity and reduces hepatic glucose production. This triple combination addresses multiple pathways of hyperglycemia, making it suitable for patients requiring intensified diabetes therapy. Ideal for Type 2 diabetes patients not adequately controlled on dual therapy. Take as directed by your healthcare provider. Store in a cool, dry place away from moisture and direct sunlight.